- Identification
- Properties
- Safety Data
- Specifications & Other Information
- Links
- Quick Inquiry
Identification
CAS Number
315-30-0
Name
Allopurinol
Synonyms
1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-on [German] [ACD/IUPAC Name]
1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one [ACD/IUPAC Name]
1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one [French] [ACD/IUPAC Name]
1H-Pyrazolo(3,4-d)pyrimidin-4-ol
2,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
206-250-9 [EINECS]
315-30-0 [RN]
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-, radical ion(1+)
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,7-dihydro- [ACD/Index Name]
691008-24-9 [RN]
7H-Pyrazolo[3,4-d]pyrimidin-4-ol
Adenock [Trade name]
Allopurin [Trade name]
Allopurinol [BAN] [INN] [JAN] [USAN] [Wiki]
Allopurinolum [Latin] [INN]
Alopurinol [Spanish] [INN]
Anoprolin [Trade name]
Bleminol [Trade name]
Caplenal [Trade name]
Cellidrin [Trade name]
Epidropal [Trade name]
Foligan [Trade name]
Hexanurat [Trade name]
Hexanuret
HPP
Isopurinol
MFCD00599413 [MDL number]
Remid [Trade name]
Sigapurol
T56 BMN GN INJ FQ [WLN]
Takanarumin [Trade name]
Urosin [Trade name]
Zyloprim [Trade name]
Zyloric [Trade name]
аллопуринол [Russian]
ألوبيرينول [Arabic]
别嘌醇 [Chinese]
7HP
Apo-Allopurinol
Uritas
[315-30-0] [RN]
1(2),5-dihydro-pyrazolo[3,4-d]pyrimidin-4-one
1-(2-Allyl-phenoxy)-3-isopropylamino-propan-2-ol
1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one
1,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one
1,5Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one Synonym : Allopurinol
1,5-Dihydropyrazolo[3,4-d]pyrimidin-4-one
1,5-Dihydro-pyrazolo[3,4-d]pyrimidin-4-one
1,7-DIHYDRO-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONE
1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-one
1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one
1H,4H,7H-pyrazolo[3,4-d]pyrimidin-4-one
1h-pyrazolo (3 4 -d)pyrimidin-4-ol
1H-pyrazolo[3,4-d]pyrimidin-4(2H)-one
1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one
1H-pyrazolo[3,4-d]pyrimidin-4(7H)-one
1H-pyrazolo3,4-dpyrimidin-4-ol
2-(dihydroxymethyl)-2,5-dihydrofuran-2,5-diol
291279-53-3 [RN]
2H-pyrazolo[3,4-d]pyrimidin-4(5H)-one
2H-pyrazolo[3,4-d]pyrimidin-4(7H)-one
2H-Pyrazolo[3,4-d]pyrimidin-4-ol (9CI)
4-HPP
4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 2,5-dihydro- (9CI)
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 2,7-dihydro- (9CI)
4h-pyrazolo[3,4-d]pyrimidin-4-one,1,2-dihydro-
4h-pyrazolo[3,4-d]pyrimidin-4-one,1,7-dihydro-
4h-pyrazolo[3,4-d]pyrimidin-4-one,2,5-dihydro-
4h-pyrazolo[3,4-d]pyrimidin-4-one,2,7-dihydro-
4-Hydroxy-1H-pyrazolo[3,4-d]pyrimidine
4-Hydroxy-3,4-pyrazolopyrimidine
4-Hydroxypyrazol[3,4-D]pyrimidine
4-Hydroxypyrazole[3,4-d]pyrimidine
4-Hydroxypyrazolyl[3,4-d]pyrimidine
4-Oxopyrazolo[3,4-d]pyrimidine
916979-34-5 [RN]
Ailural
Ailurial
ALLO
Allohexal
Allohexan
Alloinol
Alloprin
Allopur
ALLOPURINOL[3H]
Allopurinol-d2
Alloril
Allorin
Allosig
Allozym
Allpargin
Allural
Aloprim
Aloprim
Alopurinol
Aloral
Alositol
Aluline
Aluron
Anzief
Apulonga
Apurin
Apurol
Atisuril
Bloxanth
BW 56-158
BW-56-158
Capurate
cid_2094
Cosuric
Dabrosin
Dabroson
DB00437
Dura Al
Embarin
Epuric
Geapur
Gichtex
Gotax
Jenapurinol
Ketanrift
Ketobun-A
Ledopur
Lopurin
Lysuron
MFCD08234377 [MDL number]
MFCD08276167 [MDL number]
MFCD18384981
Milurit
Milurite
Miniplanor
Monarch [Wiki]
Nektrohan
Novopurol
Pan Quimica
Progout
Purinol
pyrazolo[5,4-d]pyrimidin-4-ol
Quimica, Pan
Riball
Rimapurinol
Roucol
Suspendol
Tipuric
Urbol
Uribenz
Uricemil
Uridocid
Uriprim
Uripurinol
Urobenyl
Urolit
Urtias
Urtias 100
Xanthomax
Xanturat
Xanturic
Zygout
Zyloprim
Zyloprim ;HPP
Zyrik
SMILES
c1c2c(ncnc2O)n[nH]1
StdInChI
InChI=1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)
StdInChIKey
OFCNXPDARWKPPY-UHFFFAOYSA-N
Molecular Formula
C5H4N4O
Molecular Weight
136.111
EINECS
206-250-9
MDL Number
MFCD00599413
Properties
Appearance
Off-white powder
Structure
structure of Allopurinol CAS 315-30-0
Safety Data
Symbol
Signal Word
Warning
WGK Germany
3
MSDS Download
Specifications and Other Information of Our
Identification Methods
HNMR, HPLC
Assay
98% min
Limit of Hydrazine
NMT 10 ppm (LOQ-0.2 ppm)
(In house Limit : NMT 2.5 ppm)
Residual solvent (By GC)
NMT 220 ppm(LOQ-50 ppm)
Organic Impurities
Allopurinol related compound A : NMT 0.20%
(In-house : NMT 0.10%) (LOQ-0.03%)
Allopurinol related compound B : NMT 0.20%
(In-house : NMT 0.10%) (LOQ-0.02%)
Allopurinol related compound C : NMT 0.20%
(In-house : NMT 0.10%) (LOQ-0.02%)
Allopurinol related compound D : NMT 0.20%
(In-house : NMT 0.10%) (LOQ-0.03%)
Alluµul’luul r匕lated cumpoun<l E : NMT 0.20%
(In-house : NMT 0.10%) (LOQ-0.04%)
‘Ethyl-(E/Z)-3(2-carbethoxy-2-cyanoethenyl)amino-1 H- pyrazole-4-carboxylate’: NMT 0.2% (LOQ-0.02%) Any individual unspecified impurity : NMT O.10%
(LOQ-0.02%)
Total impurities : NMT 1.0%
Loss on Drying
NMT 0.5 % (Dr)’1.0 gin vacuum at 105°C for 5 hours).
Shelf Life
5 years
Storage
Under room temperature away from light
Known Application
Allopurinol can help reduce the symptoms of muscle stiffness and tremors in individuals with Parkinson’s disease. By inhibiting the action of acetylcholine in the central nervous system, it helps reduce abnormal muscle.Parkinson’s disease patients often experience abnormal gait and coordination difficulties.Allopurinol can assist in improving these issues, leading to smoother and more coordinated walking.
Allopurinol is also used to treat excessive saliva secretion, which may occur in certain conditions and as a side effect of certain medications, including Parkinson’s disease.
General View of Documents
Links
This product is developed by our R&D company Caming Pharmaceutical Limited (http://www.caming.com/).
Quick Inquiry
Fill out our inquiry form and one of our experts will be in touch with you shortly.